Leiomyosarcoma of the Prostate: Case Report and Review of 54 Previously Published Cases
Figure 3
(a): patients with metastatic disease at presentation had worse overall survival than those with no metastatic disease (median survival for 5 months versus 20 months, resp., ). (b): patients with microscopic or gross residual disease after surgery had worse overall survival than those with microscopically negative margins after surgery (median survival for 13 months versus 41 months, resp., ).
